Do you offer adjuvant chemotherapy to patients with urachal adenocarcinoma and at least one high risk feature?
e.g. lymph node metastasis, presence of tumor involving the peritoneal surfaces and/or the abdominal wall. If so, which regimen would you offer?
1 Answer
Mednet Member
Medical Oncology · Hematology-Oncology Associates of Fredericksburg, Inc.
Answered on · Updated on
In the absence of data in this space, I would offer adjuvant chemotherapy applying similar principles from colon adenocarcinoma for patients with T4 or node positive disease. FOLFOX/CAPOX for 3 to 6 months is reasonable in this situation. This regimen has the most reliable and reproducible data in the adjuvant setting for resected colon adenocarcinoma. Extension to the anterior abdominal wall will likely make this incurable, in which case we could still consider FOLFOX/FOLFIRI in the palliative ...
Join for free or sign in to see the full answer